The detailed information for PTAB case with proceeding number IPR2014-00842 filed by Phigenix, Inc. against ImmunoGen, Inc. et al. on May 29, 2014. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2014-00842
Filing Date
May 29, 2014
Petitioner
Phigenix, Inc.
Respondent
ImmunoGen, Inc. et al.
Status
Institution Denied
Respondent Application Number
11488545
Respondent Tech Center
1600
Respondent Patent Number
7575748
Institution Decision Date
Dec 9, 2014
Termination Date
Dec 9, 2014

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Decision - Denying Institution of Inter Partes Review - 37 C.F.R. 42.108

Dec 9, 2014PAPERBOARD

Power of Attorney

Sep 10, 2014PAPERPATENT OWNER

'748 Exhibit List

Sep 10, 2014PAPERPATENT OWNER

POPR

Sep 10, 2014PAPERPATENT OWNER

Pohlmann 2009

Sep 10, 2014EXHIBITPATENT OWNER

20080709 Final Rejection

Sep 10, 2014EXHIBITPATENT OWNER

20080908 Amendment

Sep 10, 2014EXHIBITPATENT OWNER

Klencke Declaration

Sep 10, 2014EXHIBITPATENT OWNER

Mol Can Ther March

Sep 10, 2014EXHIBITPATENT OWNER

Antibody-Drug Conjugates

Sep 10, 2014EXHIBITPATENT OWNER

Power of Attorney

Jun 19, 2014PAPERINDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER.

Power of Attorney

Jun 19, 2014PAPERINDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER.

Related Matters

Jun 19, 2014PAPERINDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER.

Notice of Filing Date Accorded to Petition

Jun 10, 2014PAPERBOARD

Corrected Exhibit 1030 - Preliminary Amendment of 10-24-2008

May 30, 2014EXHIBITPETITIONER

Petition for Inter Partes Review of U.S. Patent No. 7,575,748

May 29, 2014PAPERPETITIONER

Power of Attorney

May 29, 2014PAPERPETITIONER

U.S. Patent No. 7,575,748

May 29, 2014EXHIBITPETITIONER

Slamon, et al.

May 29, 2014EXHIBITPETITIONER

Press, et al.

May 29, 2014EXHIBITPETITIONER

Phillips, et al.

May 29, 2014EXHIBITPETITIONER

Hudziak, et al.

May 29, 2014EXHIBITPETITIONER

McKenzie, et al.

May 29, 2014EXHIBITPETITIONER

Ring, et al.

May 29, 2014EXHIBITPETITIONER

HERCEPTIN Label

May 29, 2014EXHIBITPETITIONER

Blythman, et al.

May 29, 2014EXHIBITPETITIONER

Vitetta, et al.

May 29, 2014EXHIBITPETITIONER

Maier, et al.

May 29, 2014EXHIBITPETITIONER

Chari, et al.

May 29, 2014EXHIBITPETITIONER

Batra, et al.

May 29, 2014EXHIBITPETITIONER

Liu, et al.

May 29, 2014EXHIBITPETITIONER

Chari

May 29, 2014EXHIBITPETITIONER

Declaration of Michael G. Rosenblum, Ph.D.

May 29, 2014EXHIBITPETITIONER

U.S. Patent No. 5,770,195

May 29, 2014EXHIBITPETITIONER

Rosenblum, et al.

May 29, 2014EXHIBITPETITIONER

Baselga, et al.

May 29, 2014EXHIBITPETITIONER

Pegram, et al.

May 29, 2014EXHIBITPETITIONER

Morgan, et al.

May 29, 2014EXHIBITPETITIONER

Cohen

May 29, 2014EXHIBITPETITIONER

Suzuki, et al.

May 29, 2014EXHIBITPETITIONER

U.S. Patent No. 5,208,020

May 29, 2014EXHIBITPETITIONER

Office Action of December 28, 2007, in U.S. Application No. 11/488,545

May 29, 2014EXHIBITPETITIONER

Response to Office Action of December 28, 2007, filed on March 20, 2008, in U.S. Application No. 11/488,545

May 29, 2014EXHIBITPETITIONER

U.S. Patent No. 4,981,979

May 29, 2014EXHIBITPETITIONER

Lewis et al.

May 29, 2014EXHIBITPETITIONER

Office Action of July 9, 2008, in U.S. Application No. 11/488,545

May 29, 2014EXHIBITPETITIONER

Preliminary Amendment

May 29, 2014EXHIBITPETITIONER

Office Action of January 26, 2009 in U.S. Application No. 11/488,545

May 29, 2014EXHIBITPETITIONER

Baselga, et al.

May 29, 2014EXHIBITPETITIONER

Louis Weiner

May 29, 2014EXHIBITPETITIONER

Curriculum vitae of Michael G. Rosenblum, Ph.D.

May 29, 2014EXHIBITPETITIONER

Mertansine

May 29, 2014EXHIBITPETITIONER

Trastuzumab

May 29, 2014EXHIBITPETITIONER

Anti-c-ErbB2/c-Neu (Ab-5), clone TA-1

May 29, 2014EXHIBITPETITIONER

Paik, et al.

May 29, 2014EXHIBITPETITIONER

Hooijberg, et al.

May 29, 2014EXHIBITPETITIONER

Knox, et al.

May 29, 2014EXHIBITPETITIONER

Caron, et al.

May 29, 2014EXHIBITPETITIONER

Pagliaro, et al.

May 29, 2014EXHIBITPETITIONER

Sgouros, et al.

May 29, 2014EXHIBITPETITIONER